S. Benham Kahn

1.6k total citations
47 papers, 1.3k citations indexed

About

S. Benham Kahn is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, S. Benham Kahn has authored 47 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 11 papers in Genetics and 10 papers in Oncology. Recurrent topics in S. Benham Kahn's work include Acute Myeloid Leukemia Research (6 papers), Acute Lymphoblastic Leukemia research (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). S. Benham Kahn is often cited by papers focused on Acute Myeloid Leukemia Research (6 papers), Acute Lymphoblastic Leukemia research (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). S. Benham Kahn collaborates with scholars based in United States, United Kingdom and India. S. Benham Kahn's co-authors include Isadore Brodsky, Ronald F. Coburn, W. J. Williams, Peter S. Houts, Joyce M. Yasko, Katherine Marconi, C B Begg, J. J. Mazza, John M. Bennett and Heather S. Bonner and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

S. Benham Kahn

46 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Benham Kahn United States 17 321 300 292 277 259 47 1.3k
Bruce V. Stadel United States 22 194 0.6× 257 0.9× 133 0.5× 983 3.5× 265 1.0× 44 2.2k
RD Barr Canada 16 126 0.4× 358 1.2× 72 0.2× 354 1.3× 390 1.5× 47 1.2k
Simone I. Strasser Australia 38 349 1.1× 386 1.3× 184 0.6× 202 0.7× 137 0.5× 198 4.3k
Marc Ansari Switzerland 26 406 1.3× 449 1.5× 538 1.8× 566 2.0× 582 2.2× 161 2.0k
Biswajit Dubashi India 15 268 0.8× 210 0.7× 117 0.4× 176 0.6× 135 0.5× 131 883
Rodger J. Winn United States 21 1.3k 3.9× 137 0.5× 541 1.9× 378 1.4× 178 0.7× 47 2.5k
Dominique Debray France 37 447 1.4× 243 0.8× 208 0.7× 116 0.4× 343 1.3× 149 4.2k
Adriana Ceci Italy 25 204 0.6× 370 1.2× 149 0.5× 174 0.6× 709 2.7× 101 2.1k
Simon Horslen United States 35 183 0.6× 97 0.3× 265 0.9× 207 0.7× 475 1.8× 168 4.0k
M P Vessey United Kingdom 28 708 2.2× 96 0.3× 99 0.3× 671 2.4× 178 0.7× 61 2.3k

Countries citing papers authored by S. Benham Kahn

Since Specialization
Citations

This map shows the geographic impact of S. Benham Kahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Benham Kahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Benham Kahn more than expected).

Fields of papers citing papers by S. Benham Kahn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Benham Kahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Benham Kahn. The network helps show where S. Benham Kahn may publish in the future.

Co-authorship network of co-authors of S. Benham Kahn

This figure shows the co-authorship network connecting the top 25 collaborators of S. Benham Kahn. A scholar is included among the top collaborators of S. Benham Kahn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Benham Kahn. S. Benham Kahn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mainwaring, Mark, Lisa M. Rimsza, SF Chen, et al.. (2002). Treatment of Refractory Acute Leukemia with Timed Sequential Chemotherapy Using Topotecan Followed by Etoposide+Mitoxantrone (T-EM) and Correlation with Topoisomerase II Levels. Leukemia & lymphoma. 43(5). 989–999. 12 indexed citations
2.
Rajdev, Lakshmi, Zi‐Fan Yu, Scott Wadler, et al.. (2001). N-Methylformamide in Advanced Squamous Cancer of the Uterine Cervix: An Eastern Cooperative Oncology Group Phase II Trial. Investigational New Drugs. 19(3). 233–237. 5 indexed citations
3.
Ener, Rasih Atilla, David Topolsky, Michael Styler, et al.. (2001). Use of Granulocyte Colony-Stimulating Factor After High-Dose Chemotherapy and Autologous Peripheral Blood Stem Cell Transplantation. American Journal of Clinical Oncology. 24(1). 19–25. 6 indexed citations
4.
Kahn, S. Benham, S E Rubesin, Marc S. Levine, Igor Laufer, & H Herlinger. (1993). Polypoid lesions at the anorectal junction: barium enema findings.. American Journal of Roentgenology. 161(2). 339–342. 5 indexed citations
5.
Kahn, S. Benham, Peter S. Houts, & Seeromanie Harding. (1992). Quality of life and patients with cancer: A comparative study of patient versus physician perceptions and its implications for cancer education. Journal of Cancer Education. 7(3). 241–249. 40 indexed citations
6.
Schwartz, Allan B., et al.. (1992). RBC improved survival due to recombinant human erythropoietin explains effectiveness of less frequent, low dose subcutaneous therapy.. PubMed. 38(5). 283–9. 13 indexed citations
7.
Conroy, James F., David Topolsky, Pamela Crilley, et al.. (1991). High-Dose Cytosine Arabinoside and Etoposide in the Treatment of Relapsed or Refractory Adult Leukemia. American Journal of Clinical Oncology. 14(1). 52–54. 2 indexed citations
8.
Schwartz, Allan B., et al.. (1991). Cardiovascular hemodynamic effects of correction of anemia of chronic renal failure with recombinant-human erythropoietin.. PubMed. 23(2). 1827–30. 13 indexed citations
9.
Bulova, Stephen I., Pamela Crilley, David Topolsky, et al.. (1990). An Unusual Extramedullary Relapse of Acute Nonlymphocytic Leukemia After Allogeneic Bone Marrow Transplantation. American Journal of Clinical Oncology. 13(3). 238–243. 4 indexed citations
10.
Kahn, S. Benham, et al.. (1989). Attenuated High-Dose Cytosine Arabinoside in the Treatment of the Elderly Patient with Acute Nonlymphocytic Leukemia. American Journal of Clinical Oncology. 12(3). 201–204. 9 indexed citations
11.
Houts, Peter S., et al.. (1989). The Incidence and Causes of Job-Related Problems Among Employed People with Cancer in Pennsylvania. Journal of Psychosocial Oncology. 7(1-2). 19–30. 15 indexed citations
12.
Houts, Peter S., Harold A. Harvey, Arthur J. Hartz, et al.. (1988). Unmet needs of persons with cancer in pennsylvania during the period of terminal care. Cancer. 62(3). 627–634. 101 indexed citations
13.
Kahn, S. Benham. (1983). Concepts in cancer medicine. Grune & Stratton eBooks. 4 indexed citations
14.
Fiumara, Nicholas J. & S. Benham Kahn. (1982). Contact Dermatitis from a Gonococcal Discharge. Sexually Transmitted Diseases. 9(1). 41–41. 3 indexed citations
15.
Brodsky, Isadore, et al.. (1979). Myeloproliferative disorders: II CML: Clonal evolution and its role in management. Leukemia Research. 3(6). 379–393. 12 indexed citations
16.
Brodsky, Isadore, et al.. (1968). Laboratory Diagnosis of Disseminated Intravascular Coagulation. American Journal of Clinical Pathology. 50(2). 211–220. 20 indexed citations
17.
Brodsky, Isadore & S. Benham Kahn. (1967). Cancer chemotherapy: basic and clinical applications : the 15th Hahnemann symposium.
18.
Coburn, Ronald F., W. J. Williams, Peter White, & S. Benham Kahn. (1967). The Production of Carbon Monoxide from Hemoglobin In Vivo*. Journal of Clinical Investigation. 46(3). 346–356. 72 indexed citations
19.
Kahn, S. Benham & Isadore Brodsky. (1966). Vitamin B12, ascorbic acid and iron metabolism in scurvy. The American Journal of Medicine. 40(1). 119–126. 9 indexed citations
20.
Kahn, S. Benham, et al.. (1965). Methylmalonic acid excretion, a sensitive indicator of vitamin B12 deficiency in man.. Journal of Laboratory and Clinical Medicine. 66. 75–83. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026